Lexicon Pharmaceuticals, Inc. (LXRX)
1.82
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.825
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Profit Margin (Quarterly) : -4.59K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.59K% |
| March 31, 2026 | -4.94% |
| December 31, 2025 | -282.7% |
| September 30, 2025 | -90.04% |
| June 30, 2025 | 11.27% |
| March 31, 2025 | -2.00K% |
| December 31, 2024 | -127.2% |
| September 30, 2024 | -3.70K% |
| June 30, 2024 | -3.24K% |
| March 31, 2024 | -4.28K% |
| December 31, 2023 | -6.87K% |
| September 30, 2023 | -31.19K% |
| June 30, 2023 | -14.17K% |
| March 31, 2023 | -133.1K% |
| December 31, 2022 | -108.9K% |
| September 30, 2022 | -59.97K% |
| June 30, 2022 | -70.25K% |
| March 31, 2022 | -63.45K% |
| December 31, 2021 | -182.9K% |
| September 30, 2021 | -100.5K% |
| June 30, 2021 | -7.72K% |
| March 31, 2021 | -77.62K% |
| December 31, 2020 | -2.76K% |
| September 30, 2020 | |
| June 30, 2020 | -753.8% |
| Date | Value |
|---|---|
| March 31, 2020 | -832.7% |
| December 31, 2019 | -586.0% |
| September 30, 2019 | 76.78% |
| June 30, 2019 | -237.7% |
| March 31, 2019 | -236.5% |
| December 31, 2018 | -98.30% |
| September 30, 2018 | -393.3% |
| June 30, 2018 | -250.4% |
| March 31, 2018 | -164.8% |
| December 31, 2017 | -85.87% |
| September 30, 2017 | -114.0% |
| June 30, 2017 | -290.9% |
| March 31, 2017 | -190.7% |
| December 31, 2016 | -140.7% |
| September 30, 2016 | -129.9% |
| June 30, 2016 | -189.7% |
| March 31, 2016 | -279.2% |
| December 31, 2015 | 68.16% |
| September 30, 2015 | -6.23K% |
| June 30, 2015 | -7.47K% |
| March 31, 2015 | -1.57K% |
| December 31, 2014 | -13.65% |
| September 30, 2014 | -9.67K% |
| June 30, 2014 | -3.85K% |
| March 31, 2014 | -11.13K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 25.54% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.60% |
| Return on Assets | -26.91% |
| Return on Invested Capital | -29.38% |
| Gross Profit Margin (Quarterly) | 79.62% |
| Operating Margin (Quarterly) | -3.84K% |
| Return on Net Operating Assets | -106.2% |